Brief: Sciclone Pharmaceuticals (Holdings) Recommends Final Dividend Of HK$0.39 Per Share

SciClone Pharmaceuticals (Holdings)

30/03/2023 15:31

March 30 (Reuters) - SciClone Pharmaceuticals (Holdings)
Ltd  6600.HK :
    * RECOMMENDED A FINAL DIVIDEND OF HKD0.39 PER SHARE FOR YEAR
    * FY REVENUE RMB2,749.7 MILLION, UP 9.2%
    * FY CORE NET PROFIT FROM NORMAL BUSINESS OPERATIONS
RMB1,035.4
MILLION, INCREASE OF 5.6%

Source text for Eikon:  ID: 
Further company coverage:  6600.HK